The FDA has approved the XFG variant formula for U.S. use, and Pfizer is now deploying the approved vaccine doses across the United States.
5 reports, 2 independent
Updated Sep 1
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 5
- Developments
- 2
- Repetition
- 80%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The FDA has approved the XFG variant formula for U.S. use, and Pfizer is now deploying the approved vaccine doses across the United States.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- FDA guides preferred composition and Pfizer supplies vaccine to the U.S. market.Sub-event
FDA approves XFG variant formula for U.S. use; Pfizer begins deployment.1 source
Keep exploring
The entities involved
Related events
- FDA granted approval for Pfizer's updated vaccine on September 2, 2025.
- The FDA aligned vaccine formulas with global health recommendations provided by the World Health Organization.
- Lawsuit filed alleging Pfizer engaged in deceptive marketing regarding vaccine efficacy rates.
- FDA and Pfizer are seeking regulatory approval for their products.
- Roivant Sciences licensed a drug from Pfizer for regulatory approval.